Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on its impressive innovation ...

Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...

Zoetis stock plunged Thursday after the company's 2025 guidance missed forecasts, though fourth-quarter metrics beat.

Zoetis posted Q4 earnings above estimates with strong organic growth. 2025 guidance signals lower-than-expected revenue and ...

Animal healthcare company Zoetis forecast annual profit and revenue below Wall Street estimates on Thursday, partly due to a hit from a stronger dollar, sending its shares down 9% in premarket trading ...

Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2024 as well as provided ...

With a market cap of $77.6 billion, Zoetis Inc. (ZTS) is a global leader in animal health, specializing in the discovery, ...